Novolog (Pharm-Up 1966)
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. Based in Modi'in-Maccabim-Re'ut.
Novolog (Pharm-Up 1966): net income sharply down (−82.7%), sales stable (+1.0%), cash flow sharply up (+503.3%).
- Net income sharply downH1 2026
Net income: ₪1M, vs. ₪6M a year earlier, i.e. −82.7%.
- Sales stableH1 2026
Revenue: ₪958M, vs. ₪949M a year earlier, i.e. +1.0%.
- Cash flow sharply upH1 2026
Operating cash flow: ₪108M, vs. ₪18M a year earlier, i.e. +503.3%.
- Operating income stableH1 2026
Operating income: ₪14M, vs. ₪14M a year earlier, i.e. −1.3%.
What the market pays, vs. the sector
This company's valuation multiples history is being built day by day from now on.
P/E calculated on net income (trailing 12 months: last fiscal year + H1 2026 − same period a year earlier). Sector median: companies in the group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.
Dividend per share, over 5 years
Total dividends per share paid each calendar year (5 year(s) out of 5 with a payment). Source: Yahoo Finance. The current year is not complete.
Trades by executives and interested parties
6 filing(s) over 12 months · on shares: 2 increase(s) and 1 decrease(s) in holdings.
| Date | Holder | Security | Direction | Quantity | Price | |
|---|---|---|---|---|---|---|
| 09/08/2026 | Ehud Puzis Interested party | Shares | Up | 59,009,118 | ₪0.98 | Maya › |
| 04/08/2026 | The Phoenix Investments House Ltd Institutional investor | Shares | Down | 1,267,292 | ₪0.84 | Maya › |
| 05/08/2026 | Ehud Puzis Interested party | Shares | Up | 33,991,856 | ₪0.98 | Maya › |
| 01/08/2026 | Doron Eitan Executive | Options | Down | 500,000 | — | Maya › |
| 13/04/2026 | Doron Eitan Executive | Options | Up | 600,000 | — | Maya › |
| 18/08/2025 | Doron Eitan Executive | Options | Down | 406,250 | — | Maya › |
Filings submitted on Maya (executives, directors, shareholders above 5%). An increase or decrease in holdings may come from a purchase or sale on the exchange, but also from a grant or exercise of options (price "—": grant with no price). Bonds excluded. For details, see the filing on Maya.
Follow earnings · WhatsApp group TA-125Details ▾
Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.
Join the TA-125 groupDetailed figures and history
Financial summary
| S1 2026 | S1 2025 | FY 2025 | |
|---|---|---|---|
| Total assets | 2,706 | 3,058 | 2,148 |
| Current assets | 2,057 | 2,395 | 1,493 |
| Non-current assets | 649 | 662 | 655 |
| Equity | 357 | 390 | 369 |
| of which minority interests | 6 | 14 | 12 |
| Current liabilities | 2,185 | 2,492 | 1,612 |
| Non-current liabilities | 164 | 176 | 167 |
| Revenue | 958 | 949 | 1,805 |
| Gross profit | 67 | 67 | 137 |
| Operating income | 14 | 14 | 24 |
| Pre-tax income | 2 | 7 | 6 |
| Net income | 1 | 6 | 4 |
| Net income (attributable to shareholders) | 1 | 6 | 4 |
| Dividends paid | 0 | 0 | −20 |
| Operating cash flow | 108 | 18 | −1 |
In millions of shekels. The "H1" columns cover the first six months of the year.
Calculated from these figures
| S1 2026 | S1 2025 | FY 2025 | |
|---|---|---|---|
| Gross margin | 7.0% | 7.1% | 7.6% |
| Operating margin | 1.4% | 1.5% | 1.3% |
| Net margin | 0.1% | 0.6% | 0.2% |
| Current ratio (current assets / current liabilities) | 0,9 x | 1,0 x | 0,9 x |
| Equity / total assets | 13.2% | 12.8% | 17.2% |
The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.
Company overview
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and diagnostic laboratory, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division identifies and develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics, doctors therapists, and medical bodies; provides services and management tools; and operates and markets digital platforms for doctors and clinics.
Source: official company profile (Yahoo Finance), summary. Website: www.novolog.co.il
- Maya, Tel Aviv Stock Exchange: company page and reports